Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP.

Yoshimi Enose-AkahataBridgette Jeanne BilliouxShila AzodiJennifer DwyerAshley VellucciNyater NgouthSatoshi NozumaRaya MassoudIrene CorteseJoan OhayonSteven Jacobson

Published in: Annals of clinical and translational neurology (2021)

NCT01867320.

Keyphrases

clinical trial
hiv infected patients
phase ii
open label
double blind
phase iii
antiretroviral therapy